公司概覽
業務類別 Biotechnology
業務概覽 PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinicallydifferentiated medicines that provide benefits to patients with rare disorders.
公司地址 500 Warren Corporate Center Drive, Warren, NJ, USA, 07059
電話號碼 +1 908 222-7000
傳真號碼 +1 908 222-7231
公司網頁 https://www.ptcbio.com
員工數量 1047
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Mark E. Boulding Executive Vice President and Chief Legal Officer -- 20/04/2026
Ms. Christine Utter Senior Vice President, Chief Accounting Officer and Head of People Services -- 20/04/2026
Dr. Neil Almstead, PhD Chief Technical Operations Officer 美元 582.50K 20/04/2026
Mr. Eric Pauwels Chief Business Officer 美元 613.15K 20/04/2026
Dr. Lee Scott Golden, M.D. Executive Vice President and Chief Medical Officer 美元 574.67K 20/04/2026
Mr. Pierre Gravier Chief Financial Officer 美元 579.17K 20/04/2026
Dr. Matthew B. Klein, F.A.C.S.,M.D.,M.S. Director and Chief Executive Officer 美元 958.50K 20/04/2026
 
董事會成員
董事會 職務 更新日期
Ms. Jessica Caroline Chutter Director 25/03/2026
Ms. Stephanie S. Okey, M.S. Independent Director 20/04/2026
Ms. Alethia Young Independent Director 20/04/2026
Ms. Mary Smith Independent Director 20/04/2026
Ms. Emma Reeve Independent Director 20/04/2026
Dr. Allan Jacobson, PhD Independent Director 20/04/2026
Dr. Jerome Bernard Zeldis, M.D.,PhD Independent Director 20/04/2026
Mr. David P. Southwell Independent Director 20/04/2026
Dr. Matthew B. Klein, F.A.C.S.,M.D.,M.S. Director and Chief Executive Officer 20/04/2026
Dr. Glenn D. Steele, M.D., Ph.D. Independent Director 20/04/2026
Mr. Michael Schmertzler Chairman of the Board 20/04/2026
 
所屬ETF (更新日期: 25/04/2026 03:25)
代號 名稱 佔比% 持有日期
IJRiShares Core S&P Small-Cap ETF5.92%31/03/2026
IWMiShares Russell 2000 ETF2.34%31/03/2026
XBIState Street® SPDR® S&P® Biotech ETF1.66%31/03/2026
SPSMState Street SPDR Port S&P 600 Sm CpETF0.89%31/03/2026
IJTiShares S&P Small-Cap 600 Growth ETF0.85%31/03/2026
IBBiShares Biotechnology ETF0.73%31/03/2026
IWOiShares Russell 2000 Growth ETF0.64%31/03/2026
XSMOInvesco S&P SmallCap Momentum ETF0.59%31/03/2026
SLYGState Street® SPDR® S&P 600™ Sm Cp GrETF0.52%31/03/2026
SCHASchwab US Small-Cap ETF™0.48%31/03/2026
VTWOVanguard Russell 2000 ETF0.48%31/03/2026
VIOOVanguard S&P Small-Cap 600 ETF0.34%31/03/2026
VHTVanguard Health Care ETF0.27%31/03/2026
DFASDimensional US Small Cap ETF0.22%31/03/2026
FESMFidelity Enhanced Small Cap ETF0.17%31/03/2026
IWNiShares Russell 2000 Value ETF0.16%31/03/2026
PSCPrincipal US Small Cap ETF0.15%31/03/2026
PBEInvesco Biotechnology & Genome ETF0.13%31/03/2026
ITOTiShares Core S&P Total US Stock Mkt ETF0.12%31/03/2026
DFACDimensional US Core Equity 2 ETF0.11%31/03/2026
 1    2    3    4    5    6    7    8  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.